The many faces of interleukin-17 in inflammatory skin diseases

被引:82
作者
Speeckaert, R. [1 ]
Lambert, J. [1 ]
Grine, L. [1 ]
Van Gele, M. [1 ]
De Schepper, S. [1 ]
van Geel, N. [1 ]
机构
[1] Ghent Univ Hosp, Dept Dermatol, De Pintelaan 185, B-9000 Ghent, Belgium
关键词
T-HELPER; 17; GROWTH-FACTOR-BETA; ATOPIC-DERMATITIS; ALOPECIA-AREATA; TH17; CELLS; CYTOKINES INTERLEUKIN; PYODERMA-GANGRENOSUM; IL-17; EXPRESSION; SECUKINUMAB;
D O I
10.1111/bjd.14703
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Interleukin (IL)-17 is an emerging target for inflammatory skin disorders. Given the remarkable success of its therapeutic inhibition in psoriasis, the pathogenic role of this cytokine is being explored in other immune-mediated diseases. Interestingly, IL-17 is linked to particular skin conditions where its activation coincides with disease flares. The leading hypothesis for its contribution to proinflammatory signalling cascades is driving inflammasome activation. However, IL-17 stimulation also releases a range of noninflammasome-related cytokines from human skin. Furthermore, a role in cytotoxic responses and an important interplay with the microbiome is hypothesized. While treatment failure would be surprising in neutrophilic dermatoses, the picture might be more complex in lymphocyte-mediated conditions. Nonetheless, increasing insights into the pathogenesis suggest that beneficial responses are also probable in the latter conditions. Study of this pathway in the skin reveals some intriguing aspects of the IL-17-related immunological network.
引用
收藏
页码:892 / 901
页数:10
相关论文
共 76 条
[41]  
Lambiase A, 2009, MOL VIS, V15, P1449
[42]   Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials [J].
Langley, Richard G. ;
Elewski, Boni E. ;
Lebwohl, Mark ;
Reich, Kristian ;
Griffiths, Christopher E. M. ;
Papp, Kim ;
Puig, Lluis ;
Nakagawa, Hidemi ;
Spelman, Lynda ;
Sigurgeirsson, Bardur ;
Rivas, Enrique ;
Tsai, Tsen-Fang ;
Wasel, Norman ;
Tyring, Stephen ;
Salko, Thomas ;
Hampele, Isabelle ;
Notter, Marianne ;
Karpov, Alexander ;
Helou, Silvia ;
Papavassilis, Charis .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) :326-338
[43]   Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis [J].
Lebwohl, M. ;
Strober, B. ;
Menter, A. ;
Gordon, K. ;
Weglowska, J. ;
Puig, L. ;
Papp, K. ;
Spelman, L. ;
Toth, D. ;
Kerdel, F. ;
Armstrong, A. W. ;
Stingl, G. ;
Kimball, A. B. ;
Bachelez, H. ;
Wu, J. J. ;
Crowley, J. ;
Langley, R. G. ;
Blicharski, T. ;
Paul, C. ;
Lacour, J. -P. ;
Tyring, S. ;
Kircik, L. ;
Chimenti, S. ;
Duffin, K. C. ;
Bagel, J. ;
Koo, J. ;
Aras, G. ;
Li, J. ;
Song, W. ;
Milmont, C. E. ;
Shi, Y. ;
Erondu, N. ;
Klekotka, P. ;
Kotzin, B. ;
Nirula, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (14) :1318-1328
[44]   Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): Association with clinical severity and phenotype [J].
Leonardi, Salvatore ;
Cuppari, Caterina ;
Manti, Sara ;
Filippelli, Martina ;
Parisi, Giuseppe Fabio ;
Borgia, Francesco ;
Briuglia, Silvana ;
Carmavo, Patrizia ;
Salpietro, Annamaria ;
Arrigo, Teresa ;
Salpietro, Carmelo .
ALLERGY AND ASTHMA PROCEEDINGS, 2015, 36 (01) :74-81
[45]   An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa [J].
Leslie, Kieron S. ;
Tripathi, Shivani V. ;
Nguyen, Tien V. ;
Pauli, Mariela ;
Rosenblum, Michael D. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) :243-251
[46]   Association between IL17A/IL17RA Gene Polymorphisms and Susceptibility to Alopecia Areata in the Korean Population [J].
Lew, Bark-Lynn ;
Cho, Hee-Ryung ;
Haw, Sik ;
Kim, Hwi-Jun ;
Chung, Joo-Ho ;
Sim, Woo-Young .
ANNALS OF DERMATOLOGY, 2012, 24 (01) :61-65
[47]   Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa [J].
Lima, A. L. ;
Karl, I. ;
Giner, T. ;
Poppe, H. ;
Schmidt, M. ;
Presser, D. ;
Goebeler, M. ;
Bauer, B. .
BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (03) :514-521
[48]   Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis [J].
Lin, Andrew M. ;
Rubin, Cory J. ;
Khandpur, Ritika ;
Wang, Jennifer Y. ;
Riblett, MaryBeth ;
Yalavarthi, Srilakshmi ;
Villanueva, Eneida C. ;
Shah, Parth ;
Kaplan, Mariana J. ;
Bruce, Allen T. .
JOURNAL OF IMMUNOLOGY, 2011, 187 (01) :490-500
[49]   Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis [J].
Liu, Luyan ;
Okada, Satoshi ;
Kong, Xiao-Fei ;
Kreins, Alexandra Y. ;
Cypowyj, Sophie ;
Abhyankar, Avinash ;
Toubiana, Julie ;
Itan, Yuval ;
Audry, Magali ;
Nitschke, Patrick ;
Masson, Cecile ;
Toth, Beata ;
Flatot, Jerome ;
Migaud, Melanie ;
Chrabieh, Maya ;
Kochetkov, Tatiana ;
Bolze, Alexandre ;
Borghesi, Alessandro ;
Toulon, Antoine ;
Hiller, Julia ;
Eyerich, Stefanie ;
Eyerich, Kilian ;
Gulacsy, Vera ;
Chernyshova, Ludmyla ;
Chernyshov, Viktor ;
Bondarenko, Anastasia ;
Cortes Grimaldo, Rosa Maria ;
Blancas-Galicia, Lizbeth ;
Madrigal Beas, Ileana Maria ;
Roesler, Joachim ;
Magdorf, Klaus ;
Engelhard, Dan ;
Thumerelle, Caroline ;
Burgel, Pierre-Regis ;
Hoernes, Miriam ;
Drexel, Barbara ;
Seger, Reinhard ;
Kusuma, Theresia ;
Jansson, Annette F. ;
Sawalle-Belohradsky, Julie ;
Belohradsky, Bernd ;
Jouanguy, Emmanuelle ;
Bustamante, Jacinta ;
Bue, Melanie ;
Karin, Nathan ;
Wildbaum, Gizi ;
Bodemer, Christine ;
Lortholary, Olivier ;
Fischer, Alain ;
Blanche, Stephane .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (08) :1635-1648
[50]   Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome [J].
Marzano, A. V. ;
Fanoni, D. ;
Antiga, E. ;
Quaglino, P. ;
Caproni, M. ;
Crosti, C. ;
Meroni, P. L. ;
Cugno, M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 (01) :48-56